Analysis: Vaccine joy sparks share price snakes and ladders

Virus graph

Welcome news of a coronavirus vaccine has sparked a stock market shift as investors rushed to buy and sell shares. Big-name retail and other consumer stocks shunned during the pandemic were back in fashion, while lockdown stars took a hit.

Global stock markets soared after it was revealed on Monday that pharmaceutical developers Pfizer and BioNTech had successfully completed trials of a coronavirus vaccine in six countries, proving it to be 90% effective.

With the prospect of restrictions easing over the coming months, some of the darling stocks of the pandemic saw their luck turn, while other struggling companies returned to favour.

Subscription content

Please sign in now if you have a subscription or are already registered with us.

Retail Week

Register for free to continue reading provides premium, in-depth intelligence that helps retailers judge risks, spot opportunities and identify what they need to do to win in the digital economy.

Register today for a taste of our high-quality intelligence and enjoy:

  • Two free article views per calendar month on
  • Detailed analysis of current trends and events 
  • Exclusive newsletters
  • In-depth reports, videos, interviews and much more

Discover Retail Week register now

Please note, if you have recently purchased a subscription, it may take a few minutes before your account is updated.